Vitamin B12 Deficiency: When SCD Mimics Spinal Cord Injury
- Subacute combined degeneration of the spinal cord caused by vitamin B12 deficiency can closely mimic acute traumatic spinal cord injury, making prompt clinical diagnosis and emergency management difficult,...
- As outlined by the MSD Manual Professional, subacute combined degeneration is characterized by degenerative alterations impacting primarily the white matter of the spinal cord and brain as a...
- Diagnosis of subacute combined degeneration relies on clinical findings alongside confirmation of vitamin B12 deficiency, per the MSD Manual.
Subacute combined degeneration of the spinal cord caused by vitamin B12 deficiency can closely mimic acute traumatic spinal cord injury, making prompt clinical diagnosis and emergency management difficult, as documented in case reports published in medical journals like Cureus.
Clinical Presentation of Subacute Combined Degeneration
As outlined by the MSD Manual Professional, subacute combined degeneration is characterized by degenerative alterations impacting primarily the white matter of the spinal cord and brain as a result of a vitamin B12 shortage. During the initial phases, individuals suffer from diminished vibratory and position sense in their limbs, joined by hyporeflexia alongside mild-to-moderate weakness.
When the illness advances into later phases, sufferers manifest ataxia, extensor plantar responses, spasticity, and hyperreflexia coupled with missing Achilles reflexes pointing to a mix of peripheral and central signs. Usually, individuals retain their temperature, pain, and tactile sensations, although evaluating these senses can present challenges among elderly patients. Advanced cases may also present with irritability, mild depression, paranoia, delirium, confusion, and postural hypotension. The consequent mental disorientation can make it harder to distinguish the condition from Alzheimer’s disease and other age-related dementias, based on information from the MSD Manual.
Diagnostic Workup and Differential Diagnosis
Diagnosis of subacute combined degeneration relies on clinical findings alongside confirmation of vitamin B12 deficiency, per the MSD Manual. Clinicians perform a complete blood count and measure serum vitamin B12 and folate levels. Computed tomography or magnetic resonance imaging scans are conducted to exclude structural lesions, cord compression, and other potential causes of spinal symptoms.
Treatment Protocols and Prognosis
Standard medical management for subacute combined degeneration involves vitamin B12 supplementation administered orally or via intramuscular injection for severe deficiency, as outlined by the MSD Manual. Because neurological symptoms that persist for months or years can become irreversible, prompt administration is critical. Patients generally need to maintain vitamin B12 therapy indefinitely unless the specific pathophysiological trigger responsible for the deficiency is successfully resolved.
Meanwhile, a symposium published in PMC notes that studying both primary and secondary damage after spinal cord injury reveals significant potential for endogenous neuroplasticity. After a spinal cord trauma takes place, initial and subsequent injuries happen and a variety of natural mechanisms are set in motion that can either encourage or obstruct axonal reconnection originating from supralesional regions. Animal research demonstrates that external pharmacological treatments can amplify or suppress certain mechanisms to reduce inhibitory barriers that otherwise block axonal sprouting and regeneration.